These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19284376)

  • 1. Therapeutic potential of RNA interference in drug-resistant cancers.
    Lage H
    Future Oncol; 2009 Mar; 5(2):169-85. PubMed ID: 19284376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multidrug resistance by RNA interference.
    Stege A; Krühn A; Lage H
    Methods Mol Biol; 2010; 596():447-65. PubMed ID: 19949936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapeutic Approaches to Overcome ABCB1-Mediated Drug Resistance.
    Lage H
    Recent Results Cancer Res; 2016; 209():87-94. PubMed ID: 28101689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance.
    Lage H
    Curr Drug Targets; 2006 Jul; 7(7):813-21. PubMed ID: 16842213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
    Stege A; Priebsch A; Nieth C; Lage H
    Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.
    Abbasi M; Lavasanifar A; Uludag H
    Med Res Rev; 2013 Jan; 33(1):33-53. PubMed ID: 21523793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
    Coley HM
    Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different strategies to overcome multidrug resistance in cancer.
    Saraswathy M; Gong S
    Biotechnol Adv; 2013 Dec; 31(8):1397-407. PubMed ID: 23800690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
    Lin M; Hu J; Liu T; Li J; Chen B; Chen X
    Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer.
    Fatemian T; Othman I; Chowdhury EH
    Drug Discov Today; 2014 Jan; 19(1):71-8. PubMed ID: 23974068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated functional analysis of pathways influencing cancer cell drug resistance.
    Lee AJ; Kolesnick R; Swanton C
    Expert Rev Mol Med; 2009 May; 11():e15. PubMed ID: 19467173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transmembrane transporters ABCC - structure, function and role in multidrug resistance of cancer cells].
    Dębska S; Owecka A; Czernek U; Szydłowska-Pazera K; Habib M; Potemski P
    Postepy Hig Med Dosw (Online); 2011 Aug; 65():552-61. PubMed ID: 21918258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
    Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Multidrug Resistance in Cancer Stem Cells.
    Moitra K
    Biomed Res Int; 2015; 2015():635745. PubMed ID: 26649310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance.
    Naghizadeh S; Mansoori B; Mohammadi A; Sakhinia E; Baradaran B
    Curr Med Chem; 2019; 26(34):6282-6303. PubMed ID: 29611475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular physiology of receptor mediated endocytosis and its role in overcoming multidrug resistance].
    Severin ES; Posypanova GA
    Ross Fiziol Zh Im I M Sechenova; 2011 Jun; 97(6):553-65. PubMed ID: 21874867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RNA interference used for reversal of multi-drug resistance in leukemia cells -- review].
    Tian L; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1638-43. PubMed ID: 21176387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.